tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Creative Medical completes enrollment in ADAPT trial for CELZ-201
PremiumThe FlyCreative Medical completes enrollment in ADAPT trial for CELZ-201
2M ago
Creative Medical announces WHO approval of olastrocel as INN for CELZ-201
Premium
The Fly
Creative Medical announces WHO approval of olastrocel as INN for CELZ-201
2M ago
Creative Medical files to sell 2.79M shares of common stock for holders
Premium
The Fly
Creative Medical files to sell 2.79M shares of common stock for holders
3M ago
Creative Medical Technology’s CELZ-201: A Promising Step in Diabetes Treatment
PremiumCompany AnnouncementsCreative Medical Technology’s CELZ-201: A Promising Step in Diabetes Treatment
4M ago
Creative Medical Technology’s CELZ-201-DDT Study: A Potential Game-Changer for Chronic Back Pain
Premium
Company Announcements
Creative Medical Technology’s CELZ-201-DDT Study: A Potential Game-Changer for Chronic Back Pain
4M ago
Creative Medical issues letter to shareholders
Premium
The Fly
Creative Medical issues letter to shareholders
4M ago
Creative Medical Technology Holds Special Stockholder Meeting
PremiumCompany AnnouncementsCreative Medical Technology Holds Special Stockholder Meeting
9M ago
Creative Medical Technology files to sell 1.8M shares of common for holders
Premium
The Fly
Creative Medical Technology files to sell 1.8M shares of common for holders
11M ago
Creative Medical Technology price target lowered to $26 from $30 at Roth MKM
Premium
The Fly
Creative Medical Technology price target lowered to $26 from $30 at Roth MKM
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100